Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Journal of Voice : Official Journal of the Voice Foundation
|
April 17, 2023
Otolaryngologic Symptom Severity Post SARS-CoV-2 Infection
Emerson Bouldin, Shelly Sandeep, Amanda Gillespie, et al.
American Journal of Speech-Language Pathology
|
January 26, 2023
Indexing Cognitive Resource Usage for Acquisition of Initial Voice Therapy Targets
Lisa A Vinney, Raquel Tripp, Sandeep Shelly, et al.
Hospital Pediatrics
|
July 19, 2023
Making Trauma Less Traumatic: Implementing Inpatient Pediatric Screening of Acute Stress Symptoms
Jennifer Fuchs, Eric Zwemer, Amanda Gillespie, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery
|
January 17, 2018
Does CPAP Affect Patient-Reported Voice Outcomes?
Vance Hartke, Amanda Gillespie, Libby J Smith, et al.
Journal of Voice : Official Journal of the Voice Foundation
|
August 29, 2025
Using a Vortex Whistle System to Estimate Phonatory Airflow via the Phonation Quotient
Shaheen N Awan, Jordan A Awan, Heather Shaw Bonilha, et al.
Oncology Research
|
March 3, 2016
Flow Cytometric Evaluation of Double/Triple Hit Lymphoma
Christine G Roth, Amanda Gillespie-Twardy, Stanley Marks, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 9, 2025
Phase II Open-Label Trial of Brentuximab Vedotin with Pembrolizumab in PD-1-Pretreated Metastatic Non-Small Cell Lung Cancer and Metastatic Cutaneous Melanoma
Sylvia M Lee, Omid Hamid, Robert Jotte, et al.
Blood
|
September 24, 2024
Sustained benefit of zanubrutinib vs ibrutinib in patients with R/R CLL/SLL: final comparative analysis of ALPINE
Jennifer R Brown, Barbara Eichhorst, Nicole Lamanna, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 17, 2022
Zanubrutinib Versus Ibrutinib in Relapsed/Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma: Interim Analysis of a Randomized Phase III Trial
Peter Hillmen, Barbara Eichhorst, Jennifer R Brown, et al.
Future Oncology (London, England)
|
December 13, 2023
Plain language summary of zanubrutinib or ibrutinib in chronic lymphocytic leukemia that is resistant to treatment or has come back after treatment
Jennifer R Brown, Barbara Eichhorst, Peter Hillmen, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Journal of Voice : Official Journal of the Voice Foundation
|
April 17, 2023
Otolaryngologic Symptom Severity Post SARS-CoV-2 Infection
Emerson Bouldin, Shelly Sandeep, Amanda Gillespie, et al.
American Journal of Speech-Language Pathology
|
January 26, 2023
Indexing Cognitive Resource Usage for Acquisition of Initial Voice Therapy Targets
Lisa A Vinney, Raquel Tripp, Sandeep Shelly, et al.
Hospital Pediatrics
|
July 19, 2023
Making Trauma Less Traumatic: Implementing Inpatient Pediatric Screening of Acute Stress Symptoms
Jennifer Fuchs, Eric Zwemer, Amanda Gillespie, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery
|
January 17, 2018
Does CPAP Affect Patient-Reported Voice Outcomes?
Vance Hartke, Amanda Gillespie, Libby J Smith, et al.
Journal of Voice : Official Journal of the Voice Foundation
|
August 29, 2025
Using a Vortex Whistle System to Estimate Phonatory Airflow via the Phonation Quotient
Shaheen N Awan, Jordan A Awan, Heather Shaw Bonilha, et al.
Oncology Research
|
March 3, 2016
Flow Cytometric Evaluation of Double/Triple Hit Lymphoma
Christine G Roth, Amanda Gillespie-Twardy, Stanley Marks, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 9, 2025
Phase II Open-Label Trial of Brentuximab Vedotin with Pembrolizumab in PD-1-Pretreated Metastatic Non-Small Cell Lung Cancer and Metastatic Cutaneous Melanoma
Sylvia M Lee, Omid Hamid, Robert Jotte, et al.
Blood
|
September 24, 2024
Sustained benefit of zanubrutinib vs ibrutinib in patients with R/R CLL/SLL: final comparative analysis of ALPINE
Jennifer R Brown, Barbara Eichhorst, Nicole Lamanna, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 17, 2022
Zanubrutinib Versus Ibrutinib in Relapsed/Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma: Interim Analysis of a Randomized Phase III Trial
Peter Hillmen, Barbara Eichhorst, Jennifer R Brown, et al.
Future Oncology (London, England)
|
December 13, 2023
Plain language summary of zanubrutinib or ibrutinib in chronic lymphocytic leukemia that is resistant to treatment or has come back after treatment
Jennifer R Brown, Barbara Eichhorst, Peter Hillmen, et al.
Page
of 2